Abstract: Objective To discuss the diagnostic value of Fibroscan and APRI in liver fibrosis of chronic hepatitis B patients with age>40 years old and continuous normal ALT. Methods Total of 138 cases were undergone liver biopsy to determine the pathological grade. The value of LSM and APRI were detected and
compared, the area under the receiver operating curve (AUROC) were analyzed for the diagnosis of significant liver fibrosis (F≥2, F0~F1 vs F2~F4). Then the two methods were done by parallel experiments and series of experiments to discuss the diagnostic value of combined method. Results AUROC of LSM for significant liver fibrosis was 0.880, the sensitivity was 88.9% and the specificity was 76.3%. The AUROC of APRI for significant liver fibrosis was 0.865, the sensitivity was 73.3% and the specificity was 68.82%. The sensitivity of two methods in parallel diagnosis of significant liver fibrosis was 97.78%, the specificity was 68.82%, the positive predictive value was 60.27%, and the negative predictive value was 98.46%. The sensitivity for two methods in tandem diagnosing significant liver fibrosis was 60.00%, the specificity was 91.40%, the positive predictive value was 77.14%, and the negative predictive value was 82.52%. Conclusions The application of fibroscan and APRI can better diagnose liver fibrosis of patients with chronic hepatitis B, who were older than
40 and with continuous normal ALT.
|